Inactive Instrument

Press Releases Covalon Technologies Ltd Toronto S.E.

Equities

COV

CA22282D3022

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders	Mar. 08	AQ
Covalon Technologies : FY2023 AGM Management Presentation	Mar. 06	PU
Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024	Feb. 29	AQ
Covalon Announces First Quarter Fiscal 2024 Results	Feb. 28	BU
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023	Jan. 29	AQ
Covalon Announces Management Changes	Jan. 29	AQ
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO	Jan. 05	AQ
Covalon's VALGuard Gains Prestigious Recognition in the British Journal of Nursing	Nov. 16	AQ
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing	Nov. 15	BU
Covalon Announces Issuance of Deferred Share Units	23-10-23	AQ
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access Annual Scientific Meeting in Portland, OR	23-10-16	AQ
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR	23-10-13	BU
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago	23-10-11	BU
Covalon Announces Leadership Changes	23-09-27	AQ
Covalon Technologies Ltd. - Life with a Central Line, Key Considerations from the Patient's Perspective	23-09-26	AQ
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective	23-09-25	BU
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference	23-09-19	BU
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results	23-08-15	AQ
Premier Medical Journal Spotlights Covalon's VALGUARD, A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites	23-07-19	AQ
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites	23-07-18	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Covalon Technologies Ltd Toronto S.E.

Equities

COV

CA22282D3022

Press Releases

Filters